ANIMAL INTESTINAL HEALTH MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
The global animal intestinal health market is estimated to be valued at USD 4.50 Bn in 2024 and is expected to reach USD 8.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
Discover market dynamics shaping the industry request sample copy
The animal intestinal health market is expected to witness significant growth over the forecast period. The key factors driving the growth of this market include rising adoption of pets, increasing meat consumption across the world, growing focus on gut health of livestock, and advancements in gut health supplements. With growing humanization of pets, owners are increasingly concerned about gut health of their pets. This is expected to drive the demand for probiotics, prebiotics, and other supplements that maintain intestinal microbiota. Moreover, meat production is surging globally due to growing demand from developing regions. This will boost the consumption of feed additives and antibiotics that protects the gut health of cattle and poultry. Existing and emerging players in this market are focusing on new product launches, especially natural growth promoters, to cater to the increasing requirement of gut health ingredients in animal feed.
Increasing focus on gut health of livestock
Focus on gut health and intestinal microbiome of livestock is rapidly increasing across the globe. Farmers and animal nutritionists now better understand the direct impact of gut health on weight gain, feed conversion efficiency and overall health status of animals. An unhealthy digestive system makes the animals more prone to diseases and environmental stressors which leads to reduced productivity. As a result, key market players are innovating new generation of probiotic and prebiotic supplements that are specifically targeting the microbiome development and diversity in the intestines. These gut health focused feed additives modulate the immune response, reinforce gut barrier function, and facilitate optimal nutrient absorption in animals. Many academic research studies in recent years from institutions like University of Illinois and Edinburgh Napier University have highlighted the link between gut microbial equilibrium with increased immunity, higher nutrient utilization and stress resilience in poultry, cattle and pigs. Their findings suggest maintaining stability of core gut microbial communities using feed additives leads to improved performance outcomes. International organizations like FAO and OIE have also encouraged adoption of preventive gut health management practices by farmers to tackle emerging zoonotic threats and anti-microbial resistance.
Get actionable strategies to beat competition: Get instant access to report
Growing Pet Food Market
The pet food industry has witnessed explosive growth over the past decade owing to increased spending on pets. Manufacturers have launched an array of specialized food lines tailored for different life stages, breed sizes, lifestyle needs as well as health conditions of companion animals. Within this expanding market, the segment for digestive health and wellness products is gaining major traction. Companies are innovating daily to come up with gut-supportive formulations that are packed with probiotics, prebiotics, fiber and other clinically-tested ingredients. They extensively promote the benefits of such foods through online and offline channels to create awareness. Mass customization allows catering to even minor dietary requirements. Hypoallergenic and novel protein selections ensure suitable options for sensitive stomachs or cases of food intolerance. Some products with probiotic cultures and botanical extracts directly target specific issues like diarrhea, constipation or IBD. The focus is on establishing a balanced digestive environment and microbiome composition to facilitate optimal nutrient absorption. Owners find immense value in supplementing their pets' basic diets with such specialized solutions to maintain robust intestinal health in the long-run. Veterinarians also recommend such formulations while treating gastrointestinal disorders.
Key Takeaways from Analyst:
The global animal intestinal health market is expected to witness lucrative growth in the coming years. Rising consumption of meat and dairy products is fueling the demand for balanced animal feed additives to protect their intestinal health. The market participants are developing advanced probiotic and prebiotic supplements to improve nutrient absorption and digestion in livestock. North America dominated the market in previous years backed by increasing pet spending and ban on antibiotic growth promoters in poultry industry. However, Asia Pacific is projected to emerge as the fastest growing region due to surge in meat consumption and growing awareness among farmers regarding animal wellness.
On the other hand, stringent regulations regarding use of antibiotic growth promoters may negatively impact the sales volume of supplements. High research and development costs associated with development of novel microbial strains is another challenge for new entrants. To capitalize on opportunities, companies are focusing on partnerships, mergers, and acquisitions for strengthening their product portfolio and distribution network especially in emerging Asian countries. Manufacturers are coming up with online marketing strategies to educate farmers and pet owners about the benefits of maintaining optimum gut health. The future outlook for the market remains positive with technological advancements in delivery systems and ingredient optimization.
Market Challenge: High R&D costs for new products
High research and development costs associated with bringing new products to the market is a major constraint for the growth of the global animal intestinal health market. Developing innovative feed additives, prebiotics, probiotics, and postbiotics that can effectively improve gut health in livestock and pets requires extensive research and testing. Companies have to spend huge amounts of time, money and resources to understand the complex microbiome and how different ingredients impact intestinal functions. They need to closely monitor animal trials over long periods to confirm the safety, efficacy and commercial viability of potential new products. This level of R&D commitment is highly capital intensive for businesses. Government sources suggest that on average, it costs between US$ 100 and US$ 300 million and takes 8-12 years for a new animal health product to clear regulatory approvals and launch commercially. A large portion of this cost arises from the multi-phase clinical trials that are mandatory to demonstrate a new ingredient's health benefits and ensure it causes no adverse side effects even after prolonged use. Another challenge is that not all research leads to a commercially viable product in the end. Many candidates fail or underperform at various stages of testing itself. This elevates business risks and uncertainties associated with investments in R&D.
Market Opportunities: Advancing probiotic research and development
Advancing probiotic research and development could indeed present a major opportunity in the global animal intestinal health market going forward. There is significant ongoing research taking place around the world to better understand the role of probiotics in promoting intestinal balance and immunity in livestock and companion animals. As we learn more about the complex microbiome and how certain probiotic strains can support overall gut and systemic health, there is huge potential to develop more targeted and effective probiotic solutions. Research indicates that optimal intestinal health in production animals helps drive improved nutrient absorption and utilization, leading to superior growth rates, feed conversion efficiency, and disease resistance. As intensive farming continues to intensify worldwide to meet growing demand for animal proteins, strategies like probiotics that enhance productivity in a sustainable manner could see wide adoption. Probiotics minimize the need for antibiotic growth promotion and help animals better withstand stresses. This is particularly important given the long term risks of antimicrobial resistance. International agencies have also called for a reduction in the overuse of antibiotics in animal agriculture.
Discover high revenue pocket segments and roadmap to it: Get instant access to report
By Animal Type - Meeting Global Demand for Nutritious and Safe Animal Protein
In terms of animal type, production animal is expected to contribute the highest share of the market, accounting for 60.1% in 2024 owing to the growing demand for animal protein across the globe. As population and incomes rise, the consumption of meat and other animal products is increasing significantly. At the same time, there is growing concern about food safety and security issues in intensive animal farming practices. Maintaining optimal intestinal health in production animals through targeted nutrition and probiotics helps improve their growth and development. It also reduces the need for antimicrobial growth promoters and prevents spread of zoonotic diseases. Leading players are innovating new precision gut health solutions tailored for different production animals like poultry, swine and cattle. They focus on strengthening the integrity of intestinal walls and modulating immune response for higher feed conversion efficiency and animal well-being.
By Product Type - Revolution in Pet Care Standards
In terms of product type, nutrition is expected to contributes the highest share of the market, accounting for 20.12% in 2024 driven by rising awareness about species-specific nutritional requirements of companion animals. Pet owners increasingly demand premium quality foods that contain ingredients backed by scientific research to support digestive and overall health. Functional nutrition products enriched with prebiotics, probiotics or postbiotics are gaining popularity for their multifaceted gut benefits. Digestive enzymes and phytochemicals also provide targeted support. Furthermore, nutritional immunomodulators derived from plants, mushrooms, or yeast are used to balance the gut microbiota and strengthen immunity naturally. This has prompted manufacturers to innovate novel superfood blends, therapeutic diets and supplements centered around optimizing intestinal homeostasis in dogs and cats.
By Form - Expanding Range of Delivery Formats
In terms of form, dry is expected to contribute the highest share of the market, accounting for 60.12% in 2024 owing to its stability, convenience and economical production. Dry formats are the mainstay for delivering various intestinal health products like nutritional foods, probiotic supplements and digestive enzymes. They have favorable storage properties and offer versatile dosage options. However, the liquid segment is growing rapidly. This is attributed to rising consumer preference for formats with optimal bioavailability such as liquid extracts, emulsion drops, suspensions and solubilized powders. They not only aid efficient absorption but also get past the stomach acidity to deliver live microbes and other actives intact to the intestines. This has led manufacturers to offer an expanding range of palatable and portable liquid formulations for both companion and production animals.
To learn more about this report, request sample copy
North America has dominated the global animal intestinal health market. The region is expected to account for 35.2% of the market share in 2024 for several years owing to strong industry presence and efficient distribution networks in the region. The U.S. and Canada hold a significant share of the market due to growing pet ownership and increasing awareness about animal health and wellness among pet owners. Several leading brands have their headquarters located in North America and have established widespread supply chains to ensure easy availability of intestinal health products for pets and livestock animals. Besides, the large agricultural industry and developed veterinary infrastructure further support the market growth in the region.
Asia Pacific has emerged as the fastest growing regional market for animal intestinal health products over the recent past. Countries like India, China, Japan and Australia have witnessed double-digit growth rates driven by expanding meat consumption and rising focus on animal welfare practices. Rapidly growing pet population in Asia Pacific has also acted as a prime driver of intestinal health supplements for companion animals. Moreover, the increasing presence of global manufacturers through acquisitions of local players has improved product access across veterinary clinics and retail channels. However, pricing remains comparatively lower in the region due to lower production costs and viable imports from European and North American brands.
Animal Intestinal Health Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 4.50 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.6% | 2031 Value Projection: | US$ 8.01 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Dsm-firmenich (DSM), Adisseo, Cargill, Evonik Industries, Kemin Industries, Alltech, Kerry Group plc., Novozymes A/S, Karyotica Biologicals Pvt Ltd., EW Nutrition, AB Vista, AdvaCarePharma, ADM, Zoetis, Boehringer Ingelheim, Dechra Pharmaceuticals |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: The global animal intestinal health market involves products and solutions that help support and improve an animal's intestinal and digestive health. This includes probiotics, prebiotics, enzymes, acidifiers, and specialized ingredients designed to regulate microbial balance, nutrient absorption, and intestinal immunity and function. The market caters to various livestock animals as well as companion pets. Companies in this space focus on developing innovative formulations for optimal gut performance and overall animal wellness.
Share
About Author
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Credibility and Certifications
860519526
9001:2015
27001:2022
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowSelect a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
